A detailed history of Us Bancorp \De\ transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 660 shares of LGND stock, worth $74,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
660
Previous 648 1.85%
Holding current value
$74,830
Previous $54,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$82.7 - $110.11 $992 - $1,321
12 Added 1.85%
660 $66,000
Q2 2024

Aug 06, 2024

SELL
$68.53 - $87.91 $822 - $1,054
-12 Reduced 1.82%
648 $54,000
Q1 2024

May 07, 2024

BUY
$68.64 - $89.2 $3,294 - $4,281
48 Added 7.84%
660 $48,000
Q4 2023

Feb 09, 2024

BUY
$49.57 - $72.63 $26,321 - $38,566
531 Added 655.56%
612 $43,000
Q3 2023

Nov 03, 2023

SELL
$58.86 - $72.67 $11,418 - $14,097
-194 Reduced 70.55%
81 $4,000
Q2 2023

Aug 09, 2023

SELL
$69.53 - $79.33 $417 - $475
-6 Reduced 2.14%
275 $19,000
Q1 2023

May 09, 2023

BUY
$65.67 - $77.08 $16,089 - $18,884
245 Added 680.56%
281 $20,000
Q4 2022

Feb 13, 2023

SELL
$61.72 - $96.74 $987 - $1,547
-16 Reduced 30.77%
36 $2,000
Q3 2022

Oct 27, 2022

SELL
$0.01 - $107.56 $0 - $1,398
-13 Reduced 20.0%
52 $5,000
Q2 2022

Aug 01, 2022

SELL
$74.52 - $117.06 $596 - $936
-8 Reduced 10.96%
65 $6,000
Q1 2022

May 11, 2022

SELL
$94.99 - $151.56 $22,702 - $36,222
-239 Reduced 76.6%
73 $8,000
Q4 2021

Feb 11, 2022

BUY
$127.69 - $165.85 $5,618 - $7,297
44 Added 16.42%
312 $48,000
Q3 2021

Nov 10, 2021

SELL
$102.33 - $144.73 $61,398 - $86,838
-600 Reduced 69.12%
268 $38,000
Q2 2021

Aug 05, 2021

SELL
$113.03 - $155.64 $5,312 - $7,315
-47 Reduced 5.14%
868 $114,000
Q1 2021

Apr 28, 2021

BUY
$99.52 - $215.83 $58,617 - $127,123
589 Added 180.67%
915 $140,000
Q4 2020

Feb 04, 2021

SELL
$80.55 - $106.05 $75,153 - $98,944
-933 Reduced 74.11%
326 $32,000
Q3 2020

Nov 10, 2020

SELL
$89.56 - $126.72 $4,030 - $5,702
-45 Reduced 3.45%
1,259 $120,000
Q2 2020

Aug 07, 2020

SELL
$68.28 - $123.65 $41,377 - $74,931
-606 Reduced 31.73%
1,304 $146,000
Q1 2020

May 13, 2020

SELL
$63.37 - $107.88 $3,802 - $6,472
-60 Reduced 3.05%
1,910 $139,000
Q4 2019

Feb 04, 2020

SELL
$96.94 - $113.59 $28,403 - $33,281
-293 Reduced 12.95%
1,970 $206,000
Q3 2019

Nov 08, 2019

SELL
$86.25 - $120.16 $82,455 - $114,872
-956 Reduced 29.7%
2,263 $225,000
Q2 2019

Aug 13, 2019

SELL
$107.38 - $129.34 $24,160 - $29,101
-225 Reduced 6.53%
3,219 $367,000
Q1 2019

May 08, 2019

SELL
$105.93 - $142.47 $690,875 - $929,189
-6,522 Reduced 65.44%
3,444 $433,000
Q4 2018

Feb 13, 2019

BUY
$128.36 - $272.13 $274,048 - $580,997
2,135 Added 27.26%
9,966 $1.35 Million
Q3 2018

Nov 01, 2018

SELL
$211.18 - $274.49 $696,682 - $905,542
-3,299 Reduced 29.64%
7,831 $2.15 Million
Q2 2018

Aug 08, 2018

BUY
$150.77 - $207.98 $138,105 - $190,509
916 Added 8.97%
11,130 $2.31 Million
Q1 2018

May 08, 2018

SELL
$138.63 - $182.62 $105,913 - $139,521
-764 Reduced 6.96%
10,214 $1.69 Million
Q4 2017

Feb 02, 2018

BUY
$128.36 - $147.04 $314,096 - $359,806
2,447 Added 28.68%
10,978 $1.5 Million
Q3 2017

Nov 13, 2017

BUY
$120.91 - $137.94 $1.03 Million - $1.18 Million
8,531
8,531 $1.16 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.